Glanbia Plc ADR (OTCMKTS:GLAPY - Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totaling 250 shares, an increase of 152.5% from the March 31st total of 99 shares. Based on an average trading volume of 31 shares, the days-to-cover ratio is presently 8.1 days. Currently, 0.0% of the company's stock are sold short.
Analyst Upgrades and Downgrades
GLAPY has been the subject of a number of analyst reports. Zacks Research raised Glanbia to a "hold" rating in a report on Tuesday, March 3rd. Kepler Capital Markets downgraded Glanbia from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 4th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, Glanbia presently has a consensus rating of "Hold".
View Our Latest Research Report on GLAPY
Glanbia Stock Performance
GLAPY opened at $102.21 on Friday. The company has a 50-day moving average of $99.17 and a 200-day moving average of $91.12. Glanbia has a 1-year low of $52.40 and a 1-year high of $102.21. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.36 and a quick ratio of 0.81.
About Glanbia
(
Get Free Report)
Glanbia plc is a global nutrition company headquartered in Kilkenny, Ireland. The company operates through two principal divisions: Performance Nutrition and Glanbia Nutritionals. Performance Nutrition develops and markets sports and lifestyle nutrition products, including powders, bars and ready-to-drink beverages for athletes and fitness enthusiasts. Glanbia Nutritionals supplies dairy-based ingredients, specialty cheeses, whey proteins, nutrient premixes and functional food solutions to food, beverage and supplement manufacturers worldwide.
Glanbia was formed in 1997 through the merger of Avonmore Food plc and Waterford Foods plc.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Glanbia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Glanbia wasn't on the list.
While Glanbia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.